Exploring the Association of FTO rs9939609 with Type 2 Diabetes, Fasting Glucose and HbA1c in a Southeastern Mexican Region of Predominant Mayan Genetic Background
Biomolecules · 2025
DOI: 10.3390/biom15111492 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, 2025. Verfasst von Nicolas Fragoso-Bargas und 4 weiteren Autor:innen. Beteiligte Einrichtung: Mohn Center for Diabetes Precision Medicine, Department of Clinical Science, University of Bergen, 5009 Bergen, Norway. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Glycated Hemoglobin, Alpha-Ketoglutarate-Dependent Dioxygenase FTO, Blood Glucose. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Type 2 diabetes (T2D) is a multifactorial disease characterized by chronic hyperglycemia. The FTO variant rs9939609 has been widely associated with obesity, but emerging evidence suggests a broader role for T2D risk across diverse populations. However, Mayan ancestry individuals remain underrepresented in genetic studies. Thus, we evaluated the association of rs9939609 with T2D, fasting glucose, and HbA1c in a southeastern Mexican region with prevalent Mayan ancestry. Birthplace was used as a proxy for ancestry, although no formal ancestry assessment was conducted. The A allele was associated with increased risk for T2D in both additive (OR = 1.88 [1.08–3.40], p = 0.031) and dominant (OR = 2.09 [1.08–4.15], p = 0.032) models, even after adjusting for age, sex, BMI, waist circumference, and waist/hip ratio. The A allele was also associated with increased fasting glucose and HbA1c levels in the dominant model. Mediation analysis suggested that T2D may mediate the effect of rs9939609-A on glucose traits. rs9939609-A may be a risk factor for T2D and elevated glucose levels in this population. However, the results should be interpreted with caution due to the limited sample size, which may result in under- or overestimation of effect sizes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Mohn Center for Diabetes Precision Medicine, Department of Clinical Science, University of Bergen, 5009 Bergen, Norway.
- Hematology Laboratory, Regional Research Center "Dr. Hideyo Noguchi", Autonomous University of Yucatán, Yucatán 97225, Mexico.
ORCID-Profile: Nicolas Fragoso-Bargas, Litzy Naomi Toloza-Couoh, Guillermo Valencia-Pacheco, Nina Valadez-Gonzalez
Zitieren
APA
Fragoso-Bargas, N., Toloza-Couoh, L. N., Quintal-Ortiz, I., Valencia-Pacheco, G., & Valadez-Gonzalez, N. (2025). Exploring the Association of FTO rs9939609 with Type 2 Diabetes, Fasting Glucose and HbA1c in a Southeastern Mexican Region of Predominant Mayan Genetic Background. Biomolecules. https://doi.org/10.3390/biom15111492
Vancouver
Fragoso-Bargas N, Toloza-Couoh LN, Quintal-Ortiz I, Valencia-Pacheco G, Valadez-Gonzalez N. Exploring the Association of FTO rs9939609 with Type 2 Diabetes, Fasting Glucose and HbA1c in a Southeastern Mexican Region of Predominant Mayan Genetic Background. Biomolecules. 2025. doi:10.3390/biom15111492
BibTeX
@article{FragosoBargas2025,
author = {Fragoso-Bargas, Nicolas and Toloza-Couoh, Litzy Naomi and Quintal-Ortiz, Irma and Valencia-Pacheco, Guillermo and Valadez-Gonzalez, Nina},
title = {Exploring the Association of FTO rs9939609 with Type 2 Diabetes, Fasting Glucose and HbA1c in a Southeastern Mexican Region of Predominant Mayan Genetic Background},
journal = {Biomolecules},
year = {2025},
doi = {10.3390/biom15111492}
}
EUVIMED